GCTKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Glucotrack, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026
- Market cap
- $3.43M
- P/E (TTM)
- 0.0
- Dividend yield
- –
Ownership
Who owns Glucotrack's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| White Lion Capital LLC | 79,734 | 9.99% | 13G (passive) | Aug 26, 2026 |
| Drew Sycoff | 321,264 | 5.86% | 13G (passive) | Sep 5, 2024 |
| Armistice Capital, LLC | 101,075 | 9.99% | 13G (passive) | Dec 31, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul Goode | Chief Executive Officer, Director | 339 | 0.00% | Oct 7, 2025 |
| Peter C. Wulff | Chief Financial Officer | – | – | Feb 7, 2025 |
| Andrew K. Balo | Director | 4,692 | 0.04% | Oct 7, 2025 |
| Luis Malave | Director | 4,058 | 0.04% | Oct 7, 2025 |
| Brendel Victoria Carr | Director | – | – | Oct 7, 2025 |
| Erin Catherine Carter | Director | 2,148 | 0.02% | Oct 7, 2025 |
| John Ballantyne | Director, 10% owner | 2,747,717 | 25.97% | Mar 31, 2025 |
| Robert Fischell | Director | 2,045 | 0.02% | Mar 28, 2025 |
| Allen Danzig | Director | 1,922 | 0.02% | Mar 28, 2025 |
| A. Ballantyne Revocable Living Trust dated 08/01/2017 John | 10% owner | 2,743,591 | 25.93% | Mar 31, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Luis Malave Director | Oct 3, 2025 | Award | +463 | – | – | 4,058 |
| Andrew K. Balo Director | Oct 3, 2025 | Award | +1,285 | – | – | 4,692 |
| Erin Catherine Carter Director | Oct 3, 2025 | Award | +386 | – | – | 2,148 |
| Luis Malave Director | Jul 11, 2025 | Award | +1,200 | – | – | 3,595 |
| Andrew K. Balo Director | Jul 11, 2025 | Award | +3,332 | – | – | 3,407 |
| Erin Catherine Carter Director | Jul 11, 2025 | Award | +1,000 | – | – | 1,762 |
| John Ballantyne Director, 10% owner | Mar 26, 2025 | Award | +4,126 | – | – | 4,126 |
| Erin Catherine Carter Director | Mar 26, 2025 | Award | +1,896 | – | – | 45,632 |
| Luis Malave Director | Mar 26, 2025 | Award | +2,076 | – | – | 143,617 |
| Allen Danzig Director | Mar 26, 2025 | Award | +1,498 | – | – | 1,922 |
| Andrew K. Balo Director | Mar 26, 2025 | Award | +4,490 | – | – | 4,490 |
| Robert Fischell Director | Mar 26, 2025 | Award | +1,498 | – | – | 2,045 |
| Luis Malave Director | Mar 25, 2025 | Award | +35 | – | – | 2,395 |
| Andrew K. Balo Director | Mar 25, 2025 | Award | +75 | – | – | 75 |
| Erin Catherine Carter Director | Mar 25, 2025 | Award | +32 | – | – | 762 |
| Paul Goode Chief Executive Officer, Director | Mar 25, 2025 | Other | +42 | – | – | 339 |
| John Ballantyne Director, 10% owner | Mar 12, 2025 | Option exercise | +2,560,553 | – | – | 2,743,591 |
| Erin Catherine Carter Director | Mar 12, 2025 | Option exercise | +40,297 | – | – | 43,736 |
| A. Ballantyne Revocable Living Trust dated 08/01/2017 John 10% owner | Mar 12, 2025 | Option exercise | +2,560,553 | – | – | 2,743,591 |
| Luis Malave Director | Mar 12, 2025 | Option exercise | +133,532 | – | – | 141,541 |
| Paul Goode Chief Executive Officer, Director | Mar 12, 2025 | Option exercise | +15,435 | – | – | 18,989 |
| Paul Goode Chief Executive Officer, Director | Feb 5, 2025 | Other | +1,500 | – | – | 3,554 |
| John Ballantyne Director, 10% owner | Nov 14, 2024 | Other | +132,036 | $31.00 | $4.09M | 183,039 |
| Erin Catherine Carter Director | Nov 14, 2024 | Conversion | +2,078 | $31.20 | $64.83K | 3,439 |
| A. Ballantyne Revocable Living Trust dated 08/01/2017 John 10% owner | Nov 14, 2024 | Other | +132,036 | $31.00 | $4.09M | 183,039 |
| Luis Malave Director | Nov 14, 2024 | Conversion | +6,886 | $31.20 | $214.84K | 8,009 |
| Paul Goode Chief Executive Officer, Director | Nov 14, 2024 | Conversion | +796 | $31.20 | $24.84K | 2,054 |
| Drew Sycoff Director, 10% owner | Apr 22, 2024 | Buy | +182,539.6 | $1.26 | $230.00K | 2,951,258 |
| Erin Catherine Carter Director | Apr 8, 2024 | Award | +458 | – | – | 1,361 |
| Luis Malave Director | Apr 8, 2024 | Award | +489 | – | – | 1,123 |
| Allen Danzig Director | Apr 8, 2024 | Award | +229 | – | – | 424 |
| Robert Fischell Director | Apr 8, 2024 | Award | +229 | – | – | 547 |
| Erin Catherine Carter Director | Dec 31, 2023 | Award | +903 | – | – | 903 |
| Luis Malave Director | Dec 31, 2023 | Award | +362 | – | – | 634 |
| Luis Malave Director | Apr 20, 2023 | Award | +121 | – | – | 272 |
| Luis Malave Director | Jan 9, 2023 | Award | +29 | – | – | 151 |
| Luis Malave Director | Oct 4, 2022 | Award | +44 | – | – | 122 |
| Allen Danzig Director | Oct 4, 2022 | Award | +44 | – | – | 195 |
| Luis Malave Director | Jun 30, 2022 | Award | +34 | – | – | 78 |
| Luis Malave Director | Mar 31, 2022 | Award | +25 | – | – | 44 |
| Luis Malave Director | Dec 31, 2021 | Award | +11 | – | – | 19 |
| Luis Malave Director | Sep 30, 2021 | Award | +8 | – | – | 8 |
| Robert Fischell Director | Aug 24, 2021 | Award | +318 | – | – | 318 |
| Angela Strand Boydston Director | Mar 20, 2017 | Award | +13,334 | – | – | 13,334 |
| Angela Strand Boydston Director | Mar 20, 2017 | Award | +4,445 | – | – | 4,445 |
| Leslie Seff Director | Mar 20, 2017 | Award | +3,334 | – | – | 3,334 |
| Zvi Cohen Director | Mar 11, 2015 | Other | −120,077 | – | – | 241,625 |
| David Malka Vice President of Operations, Director | Mar 11, 2015 | Other | −61,471 | – | – | 123,695 |
| Avner Gal Chairman and CEO, Director | Mar 11, 2015 | Other | −136,162 | – | – | 273,989 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.